Literature DB >> 19828949

Visuospatial dysfunction may be a key in the differentiation between Alzheimer's disease and subcortical cognitive impairment in moderate to severe stages.

T Fukui1, E Lee, M Kitamura, H Hosoda, C Bokui, K Ikusu, K Okita.   

Abstract

AIMS: Recent studies have suggested that subcortical cognitive impairment (SubCI) and Alzheimer's disease (AD) can be differentiated by visuospatial tasks. We addressed at what severity stage these differences become apparent and what components in visuospatial processes are subject to impairment.
METHODS: Sixty patients with AD, 22 with vascular cognitive impairment and 63 with extrapyramidal diseases with cognitive impairment were assessed using the revised Hasegawa Dementia Scale (HDSR), clock drawing/reading/matching tests (CDT, CRT, CMT), figure copying (FIG) and Frontal Assessment Battery (FAB). Patients were categorized according to the HDSR scores in order to control for the severity of global cognitive impairment. Raw scores were converted to Z-scores for comparisons.
RESULTS: In the mild stage, results of all measures were comparable between AD and SubCI. In the moderate-severe stage, scores of CDT, CRT, CMT, FIG and FAB were significantly lower in SubCI. The results suggest that (given that global cognition is controlled for) visuo-perception, visuo-construction and semantic-numerical analyses of visual information may be more impaired in SubCI than AD.
CONCLUSIONS: AD and SubCI may be difficult to be differentiated in the mild stages, and the visuospatial cognitive system may be extensively defective in SubCI. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19828949     DOI: 10.1159/000245157

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  2 in total

Review 1.  Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms.

Authors:  Naoyuki Sato; Ryuichi Morishita
Journal:  Front Endocrinol (Lausanne)       Date:  2014-09-05       Impact factor: 5.555

2.  Validation of the R2CHADS2 and CHADS2 Scores for Predicting Post-stroke Cognitive Impairment.

Authors:  Kazuo Washida; Hisatomo Kowa; Hirotoshi Hamaguchi; Fumio Kanda; Tatsushi Toda
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.